Mon–Thu 8am–4:30pm CT · Fri 8am–3pm CT
Clinical Trial · NCT04367948
Overview
To evaluate the normal physiological distribution of positron nuclide labeled NOTA-F API in human body and its detection efficiency for lymphoma
Sponsor
Peking University Cancer Hospital & Institute
Phase
N/A
Contacts
Zhi Yang, PhD (STUDY_DIRECTOR)
Xuejuan Wang, MD (CONTACT)
xuejuan_wang@hotmail.com
86 010 88196363
ClinicalTrials.gov
NCT04367948Drug / Compound
Eligibility
Help us improve your experience